Standard Biotools (LAB) Gains from Investment Securities (2024 - 2025)
Standard Biotools' (LAB) quarterly Gains from Investment Securities came in at -$2.9 million in Q4 2025, down 721.31% year-on-year from $474000.0 in Q4 2024, and down 192.96% on a QoQ basis from $3.2 million in Q2 2025.
Standard Biotools (LAB) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Standard Biotools (LAB) has 2 years of Gains from Investment Securities data on file, last reported at -$2.9 million in Q4 2025.
- On a quarterly basis, Gains from Investment Securities fell 721.31% year-over-year to -$2.9 million in Q4 2025; TTM through Mar 2026 was $223000.0, a 105.24% increase from a year earlier, with the FY2025 full-year figure at -$3.2 million, changed N/A from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$2.9 million, down from $3.2 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for LAB reached as high as $3.2 million in Q2 2025 and fell as low as -$3.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Standard Biotools | 299.46 Mn | -155.72 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.95 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Dec 31, 2024 | 474,000.00 |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Jun 30, 2024 | -853,000.00 |
| Jun 30, 2024 | -853,000.00 |
| Mar 31, 2024 | 853,000.00 |
| Mar 31, 2024 | 853,000.00 |